All About Eye Drops: Warnings To Six Homeopathic And Two Allopathic Firms; Seven US, One Swiss

Common across warnings is all the firms, retailers as well as manufacturers, are marketing OTC eye drops with noncompliant claims, including “prevent or improve cataracts” and “temporarily alleviate blepharitis symptoms.” One also had GMP problems.

• Source: Shutterstock

Eight businesses recently received US Food and Drug Administration warning letters about OTC drugs “especially concerning from a public health perspective.”

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Compliance

More from Policy & Regulation